Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 27 resultados

QUANTUM: Quality Utility and Maturity Measured Developing a Data Quality and Utility Label for HealthData@E... CHU HOPITAUX DE BORDEAUX participó en un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 Context: Data users (i.e., researchers, innovators, regulation agencies and policy-makers) need high-quality data. In HealthData@EU, data ho...
2023-12-11 - 2026-06-30 | Financiado

SMHEART: Smart Cardiac Magnetic Resonance Delivering One-Click and Comprehensive Assessment of Cardiovascular... CHU HOPITAUX DE BORDEAUX participó en un HORIZON EUROPE: ERC-2022-STG Cardiovascular disease (CVD) causes at least 1.8 million European deaths annually, exceeding fatalities from cancer, chronic respiratory dis...
2023-06-14 - 2028-08-31 | Financiado

PROMINENT: PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE CHU HOPITAUX DE BORDEAUX participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million...
2023-04-25 - 2028-04-30 | Financiado

HORUS: Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation CHU HOPITAUX DE BORDEAUX participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "Solid organ transplantation (SOT) is the treatment of choice for end-stage organ failure but the immunosuppressive drugs used to prevent gr...
2022-05-30 - 2027-10-31 | Financiado

GERONTE: Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient oriente... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-SC1-BHC-2018-2020 Population is aging and the number of complex multimorbid patients to manage will increase sharply. Disease-centred approach is not appropri...
2021-01-25 - 2026-03-31 | Financiado

BEAT AF: Ground BrEAking Electroporation based inTervention for Atrial Fibrillation treatment BEAT AF CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-SC1-BHC-2018-2020 Atrial fibrillation (AF), the most common arrhythmia, accounts for 1/3rd of Cardiovascular expenses, with over 10 millions affected in Europ...
2021-01-18 - 2026-02-28 | Financiado

MAP-IN-HEART: Computed tomography targets for efficient guidance of catheter ablation in ventricular tachycardia CHU HOPITAUX DE BORDEAUX participó en un H2020: ERC-2019-PoC Patients at risk of ventricular tachycardia (VT), the primary cause of sudden cardiac death, commonly undergo catheter ablation to cauterize...
2020-03-20 - 2022-08-31 | Financiado

IP-cure-B: Immune profiling to guide host directed interventions to cure HBV infections CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-SC1-BHC-2018-2020 The objective of the project is to develop novel curative concepts for chronic hepatitis B (CHB). Specific aims will be to: 1) improve the r...
2019-12-05 - 2024-12-31 | Financiado

EBOVAC3: Bringing a prophylactic Ebola vaccine to licensure CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-JTI-IMI2-2015-08-single-stage The overall aim of EBOVAC3 is to support an essential part of remaining clinical and manufacturing activities required for licensure in the...
2018-06-15 - 2024-09-30 | Financiado

PRESTIGE-AF: PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-SC1-2016-2017 Intracerebral hemorrhage (ICH) is a severe stroke subtype causing higher mortality and more disability than other strokes. 20% of ICH surviv...
2017-12-05 - 2024-11-30 | Financiado

ROADMAP: Real world Outcomes across the AD spectrum for better care Multimodal data Access Platform Sofia... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage The aim of ROADMAP is to provide the foundation for a Europe-wide real world evidence (RWE) platform in AD by piloting multi-modal data inte...
2016-12-21 - 2018-10-31 | Financiado

BEAt-DKD: Biomarker Enterprise to Attack DKD Sofia ref. 115974 CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-JTI-IMI2-2015-05-two-stage Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached e...
2016-12-20 - 2023-08-31 | Financiado

PAPA-ARTIS: Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with Minimally Invasive... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-SC1-2016-2017 Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time but continue t...
2016-12-12 - 2024-09-30 | Financiado

ECSTATIC: Electrostructural Tomography Towards Multiparametric Imaging of Cardiac Electrical Disorders CHU HOPITAUX DE BORDEAUX participó en un H2020: ERC-2016-STG Cardiac electrical diseases are directly responsible for sudden cardiac death, heart failure and stroke. They result from a complex interpla...
2016-11-16 - 2022-07-31 | Financiado

EHVA: European HIV Vaccine Alliance EHVA a EU platform for the discovery and evaluation of novel prophy... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-PHC-2014-2015 Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. T...
2015-12-17 - 2023-12-31 | Financiado

SENSE-Cog: Ears Eyes and Mind The SENSE Cog Project to improve mental well being for elderly Europeans with... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-PHC-2014-2015 Mental, cognitive, vision and hearing health problems in elderly people are amongst the top 10 public health challenges in Europe. They freq...
2015-12-09 - 2022-06-30 | Financiado

MEDIT-AGEING: Investigating the impact of meditation training on mental health and wellbeing in the ageing populat... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-PHC-2014-2015 As the number of older people in Europe grows, increasing healthy life years is a priority. Cognitive decline, dementia (e.g. Alzheimer’s di...
2015-12-09 - 2022-03-31 | Financiado

RESSTORE: REgenerative Stem cell therapy for STroke in Europe CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-PHC-2014-2015 Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and co...
2015-09-15 - 2020-08-31 | Financiado

EBOVAC2: Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime Boost Regimen Phase II So... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-JTI-IMI2-2014-02-single-stage The main objective therefore of EBOVAC 2 is to provide extensive and robust data on the safety, immunogenicity and efficacy of the Ad26.ZEBO...
2015-03-06 - 2021-05-31 | Financiado

EBOVAC1: Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime Boost Regimen Sofia ref.... CHU HOPITAUX DE BORDEAUX participó en un H2020: H2020-JTI-IMI2-2014-02-single-stage The overall aim of the EBOVAC programme is to assess the safety and efficacy of a novel prime boost prophylactic vaccine regimen against Ebo...
2015-03-05 - 2021-11-30 | Financiado

CHU Bordeaux